[HTML][HTML] Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials
Renal cell carcinoma (RCC) is recognized as one of the three primary malignant tumors
affecting the urinary system, posing a significant risk to human health and life. Despite …
affecting the urinary system, posing a significant risk to human health and life. Despite …
Public neoantigens in breast cancer immunotherapy
N Sueangoen, P Thuwajit… - International …, 2024 - spandidos-publications.com
Among women globally, breast cancer is the most prevalent cancer and the leading cause of
cancer-related death. Interestingly, though genetic mutations contribute to the disease,< …
cancer-related death. Interestingly, though genetic mutations contribute to the disease,< …
The future of cellular therapy for the treatment of renal cell carcinoma
N Chaoul, E Lauricella, A Giglio… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Systemic treatment options for renal cell carcinoma (RCC) have expanded
considerably in recent years, and both tyrosine kinase inhibitors and immune checkpoint …
considerably in recent years, and both tyrosine kinase inhibitors and immune checkpoint …
Molecular imaging of renal cell carcinomas: ready for prime time
Q Wu, H Shao, W Zhai, G Huang, J Liu, J Calais… - Nature Reviews …, 2024 - nature.com
The clinical diagnosis of renal cell carcinoma (RCC) is constantly evolving. Diagnostic
imaging of RCC relying on enhanced computed tomography (CT) and magnetic resonance …
imaging of RCC relying on enhanced computed tomography (CT) and magnetic resonance …
268 Next generation binding: measuring cell avidity to fully characterize cell-cell interactions and understand mechanism of action for cellular therapies
Background While conventional assays such as affinity, cytokine secretion, and cytotoxicity
provide valuable data at a molecular level, this information is insufficient to fully characterize …
provide valuable data at a molecular level, this information is insufficient to fully characterize …
Recent advances and progress in immunotherapy of solid cancers.
A Kumar, L Emdad, SK Das… - Advances in Cancer …, 2024 - europepmc.org
Adoptive cell therapy using chimeric antigen receptor (CAR) technology has become
mainstream by employing advanced engineering platforms to promote cancer …
mainstream by employing advanced engineering platforms to promote cancer …